Loxapine Capsules, USP 50 mg, Rx Only, 100-count bottles, NDC 0378-7050-01
Recall Number: D-0825-2018
Firm: Mylan Pharmaceuticals Inc.
Classification: Class II
Status: Terminated
Report Date: 20180530
Initiation Date: 20180424
Termination Date: 20190814
Reason for Recall
CGMP Deviations
Product Description
Loxapine Capsules, USP 50 mg, Rx Only, 100-count bottles, NDC 0378-7050-01